Depression up in post-radiation head and neck cancer survivors

August 16, 2013
Depression up in post-radiation head & neck cancer survivors
For post-radiotherapy survivors of head and neck cancer, depression is fairly common, but treatment is underutilized, according to research published online Aug. 15 in JAMA Otolaryngology-Head & Neck Surgery.

(HealthDay)—For post-radiotherapy survivors of head and neck cancer, depression is fairly common, but treatment is underutilized, according to research published online Aug. 15 in JAMA Otolaryngology-Head & Neck Surgery.

Allen M. Chen, M.D., from the University of California in Davis, and colleagues conducted a cross-sectional analysis involving 211 patients with squamous cell carcinoma of the head and neck, who had been previously treated with radiotherapy, to determine the prevalence of self-reported . Rates of depression were analyzed using the self-administered University of Washington Quality of Life Instrument.

The researchers observed no difference in the mean mood score at one, three, and five years after treatment. At one, three, and five years, respectively, 17, 15, and 13 percent of patients reported their mood as somewhat or extremely depressed. The presence of tracheostomy tube or laryngeal stoma, gastrostomy tube dependence, and continued smoking at follow-up correlated significantly with post-radiotherapy depression. At one, three, and five years of follow-up, the proportion of those who were somewhat or extremely depressed and were using antidepressants was 6, 11, and 0 percent, respectively, while 3, 6, and 0 percent, respectively, were actively undergoing psychotherapy and/or counseling.

"Despite a relatively high rate of depression among with in the post-radiotherapy setting, mental health services are severely underutilized," the authors write.

Explore further: Tonsillectomy pre-radiation ups survival in early tonsil CA

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Tonsillectomy pre-radiation ups survival in early tonsil CA

April 19, 2013
(HealthDay)—For patients with stage I and II primary tonsil carcinoma, radiotherapy after tonsillectomy is associated with improved overall survival (OS) and disease-specific survival (DSS), compared with radiotherapy after ...

Racial disparity in head and neck cancer outcomes

April 19, 2013
(HealthDay)—Among Medicaid beneficiaries diagnosed with head and neck cancer, considerable racial disparities exist in treatment patterns and survival, according to a study published online April 18 in JAMA Otolaryngology-Head ...

Newer radiation technology improves head and neck cancer patients' long-term quality of life

January 26, 2012
Patients treated with IMRT for head and neck cancer report an increasingly better quality of life post-treatment when compared to patients receiving other forms of radiation therapy, according to a study presented at the ...

Most cancer survivors have good psychological outcomes

June 30, 2013
(HealthDay)—Certain factors predict anxiety, depression, and comorbid anxiety-depression at one year in adult cancer survivors, according to research published online June 17 in the Journal of Clinical Oncology.

Carbon ion radiotherapy safe and effective for treating inoperable spinal tumors

August 12, 2013
A new analysis has found that a type of radiation therapy called carbon ion radiotherapy can control cancer growth and prolong survival in patients with spinal tumors. Published early online in Cancer, a peer-reviewed journal ...

Recommended for you

Researchers develop a remote-controlled cancer immunotherapy system

January 15, 2018
A team of researchers has developed an ultrasound-based system that can non-invasively and remotely control genetic processes in live immune T cells so that they recognize and kill cancer cells.

Pancreatic tumors may require a one-two-three punch

January 15, 2018
One of the many difficult things about pancreatic cancer is that tumors are resistant to most treatments because of their unique density and cell composition. However, in a new Wilmot Cancer Institute study, scientists discovered ...

New immunotherapy approach boosts body's ability to destroy cancer cells

January 12, 2018
Few cancer treatments are generating more excitement these days than immunotherapy—drugs based on the principle that the immune system can be harnessed to detect and kill cancer cells, much in the same way that it goes ...

Cancer's gene-determined 'immune landscape' dictates progression of prostate tumors

January 12, 2018
The field of immunotherapy - the harnessing of patients' own immune systems to fend off cancer - is revolutionizing cancer treatment today. However, clinical trials often show marked improvements in only small subsets of ...

FDA approves first drug for tumors tied to breast cancer genes

January 12, 2018
(HealthDay)—The U.S. Food and Drug Administration on Friday approved the first drug aimed at treating metastatic breast cancers linked to the BRCA gene mutation.

Breast cancer gene does not boost risk of death: study

January 12, 2018
Young women with the BRCA gene mutation that prompted actress Angelina Jolie's pre-emptive and much-publicised double mastectomy are not more likely to die after a breast cancer diagnosis, scientists said Friday.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.